<DOC>
	<DOCNO>NCT02121522</DOCNO>
	<brief_summary>The present trial use open label design investigate effect BI 144807 central 1-mm retinal thickness presence neovascular leakage newly diagnose wAMD patient . A objective collect data adverse event , vital sign , ECG clinical laboratory parameter BI 144807 patient group .</brief_summary>
	<brief_title>A 4 Week Study With BI 144807 Patients &gt; = 50 Years With Wet Age Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>Inclusion criterion : Newly diagnose men woman unilateral subfoveal choroideal neovascularization secondary agerelated macular degeneration Exclusion criterion : Additional eye disease could compromizse best correct visual acuity , uncontrolled glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>